Neogen raises FY26 revenue view to $845M-$855M from $820M-$840M

Consensus $825M. Narrows FY26 adjusted EBITDA view to $175M from $165M-$175M. The company said, “The Company is raising its full-year outlook for fiscal year 2026. Revenue is anticipated to be in the range of $845 million to $855 million and Adjusted EBITDA is expected to be approximately $175 million. Capital expenditures continue to be expected to total approximately $50 million.”